|
Endra Life Sciences Inc (NASDAQ: NDRA) |
|
Endra Life Sciences Inc
NDRA's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Endra Life Sciences Inc 's sales fell
in III. Quarter 2024 from the same quarter a year ago.
Medical Equipment & Supplies industry recorded
growth of revenues by 1.71 %
Endra Life Sciences Inc net loss decreased from $-3 millions, to $-2 millions in III. Quarter 2024,
• More on NDRA's Growth
|
|
Endra Life Sciences Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 0.03 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
44.41 |
PE TTM
|
|
Medical Equipment & Supplies industry's Price to Sales ratio is at 5.23.
• More on NDRA's Valuation
|
|
|
|
|
Endra Life Sciences Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 0.03 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
44.41 |
PE TTM
|
|
Medical Equipment & Supplies industry's Price to Sales ratio is at 5.23.
Endra Life Sciences Inc Price to Book Ratio is at 0.01 higher than Industry Avg. of -194.94, and equal to S&P 500 Avg. of 0.01
• More on NDRA's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com